The Impact of Medical Device Associated Candida Infections on Immunocomprised Patient Outcomes in A Tertiary Care Settings
DOI:
https://doi.org/10.58222/juvokes.v3i2.1067Kata Kunci:
Medical device-associated infections, Candida infections, Immunosuppressed patients, Central-line-associated bloodstream infectionsAbstrak
Medical practice across all specialties increasingly relies on the insertion or implantation of medical devices, yet these interventions carry inherent risks of bacterial and fungal infections of particular concern is the shifting epidemiology of Candida infections, where non-albicans Candida species now predominate in cases of hematogenously disseminated candidiasis in many healthcare institutions. These device-associated Candida infections represent a significant threat to patient outcomes, characterized by the organism's ability to adhere to device surfaces and proliferate as multicellular communities within self-produced extracellular matrices. The pathogenic process involves colonization of foreign materials, including intravascular catheters, urinary catheters, dentures, and various implanted medical devices, leading to resistant infections that are particularly challenging to treat. These device-associated infections can progress to Candida bloodstream infections, which are associated with significant mortality rates. However, research indicates that optimized diagnostic approaches and therapeutic management strategies can substantially improve patient outcomes. This mini-review aims to identify and address frequently overlooked opportunities in the management of device-associated Candida bloodstream infections, with particular emphasis on Early recognition and diagnosis of device-associated infections. Implementation of evidence-based preventive measures. Optimization of therapeutic interventions. Special considerations for high-risk and immunocompromised patients.
Referensi
Agvald-Öhman, C., Klingspor, L., Hjelmqvist, H., & Edlund, C. (2008). Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome. Scandinavian Journal of Infectious Diseases, 40(2), 145–153. https://doi.org/10.1080/00365540701534509
Apurba S Sastry M D, DN B MNAMS PDCR, Sandhya Bhat M D DNB MNAMS Essentials of microbiology, 3rd Edition
A. N., Pagani, F. D., & Malani, P. N. (2009). Fungemia associated with left ventricular assist device support. Journal of Cardiac Surgery, 24(6), 763-765.
Bagdasarian, N. G., Malani, A. N., Pagani, F. D., & Malani, P. N. (2009). Fungemia associated with left ventricular assist device support. Journal of Cardiac Surgery, 24(6), 763-765.
Cauda, R. (2009). Candidemia in patients with an inserted medical device. Drugs, 69, 33-38.
Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2012). Candida biofilms associated with CVC and medical devices. Mycoses, 55, 46-57.
Chiou, C. C., Wong, T. T., Lin, H. H., Hwang, B., Tang, R. B., Wu, K. G., & Lee, B. H. (1994). Fungal infection of ventriculoperitoneal shunts in children. Clinical infectious diseases, 19(6), 1049-1053.
Dadi, N. C. T., Radochová, B., Vargová, J., & Bujdáková, H. (2021). Impact of healthcare-associated infections connect.
Dimopoulos, G., et al. "Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative study." European Journal of Clinical Microbiology & Infectious Diseases 26 (2007): 377-384.ed to medical devices—An update. Microorganisms, 9(11), 2332.
Francolini, I., & Donelli, G. (2010). Prevention and control of biofilm-based medical-device-related infections. FEMS Immunology & Medical Microbiology, 59(3), 227-238.
Ghrenassia, E., Mokart, D., Mayaux, J., Demoule, A., Rezine, I., Kerhuel, L., Calvet, L., De Jong, A., Azoulay, E., & Darmon, M. (2019). Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study. Annals of Intensive Care, 9(1). https://doi.org/10.1186/s13613-019-0539-2
.Lockhart, S. R. (2014). Current Epidemiology of Candida Infection. Clinical Microbiology Newsletter, 36(17), 131–136. https://doi.org/10.1016/j.clinmicnews.2014.08.001
Mellinghoff, S. C., Cornely, O. A., & Jung, N. (2018). Essentials in Candida bloodstream infection. Infection, 46(6), 897–899. https://doi.org/10.1007/s15010-018-1218-1
Montero, A., Romero, J., Vargas, J. A., Regueiro, C. A., Sanchez-Aloz, G., De Prados, F., ... & Aragon, G. (2000). Candida infection of cerebrospinal fluid shunt devices: report of two cases and review of the literature. Acta neurochirurgica, 142, 67-74.
Puebla, L. J. (2012). Fungal infections in immunosuppressed patients. immunodeficiency.
Pierrotti, L. C., & Baddour, L. M. (2002). Fungal Endocarditis, 1995–2000. Chest, 122(1), 302-310.
Nett, J. E., Zarnowski, R., Cabezas-Olcoz, J., Brooks, E. G., Bernhardt, J., Marchillo, K., ... & Andes, D. R. (2015). Host contributions to construction of three device-associated Candida albicans biofilms. Infection and Immunity, 83(12), 4630-4638.
Von Eiff, C., Jansen, B., Kohnen, W., & Becker, K. (2005). Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs, 65, 179-214.
_1.png)
